Glympse: Jonathan Wilde

Biosensor-based diagnostic company Glympse has appointed Jonathan Wilde as the firm's CSO. Wilde was previously VP of research and collaborations at Veracyte and worked in biomarker discovery and diagnostic development across multiple disease areas at pharmaceutical firms AstraZeneca and GlaxoSmithKline. Wilde has also worked as a consultant for companies like Owlstone Medical and Cytox.